계피(시나몬)의 항염증, 항암, 항당뇨 효과에 대한 review - 논문 읽어야

[문형철]

beyond reason

자연의 선물에 감사하며

시나몬의 헬리코박터 파일로리 제균효과에 대한 논문

- 나중에 찾아서 읽어야

Beneficial Effects of Cinnamon on the Metabolic Syndrome, Inflammation, and Pain, and Mechanisms Underlying These Effects – A Review

Yan Shen,1,* Liu-Nan Jia,2 Natsumi Honma,1 Takashi Hosono,1 Toyohiko Ariga,1 and  Taiichiro Seki1,*

Author information Copyright and License information Disclaimer

This article has been cited by other articles in PMC.

Go to:

Abstract

Cinnamon is one of the most important herbal drugs and has been widely used in Asia for more than 4000 years. As a folk medicine, cinnamon has been traditionally applied to the treatment of inflammatory disorders and gastric diseases. After chemical profiling of cinnamon's components, their biological activities including antimicrobial, antiviral, antioxidant, antitumor, antihypertension, antilipemic, antidiabetes, gastroprotective and immunomodulatory were reported by many investigators. As a result, current studies have been performed mostly focusing on the bioactivity of cinnamon toward the recently generalized metabolic syndrome involving diabetes. In this review article, we provide an overview of the recent literature describing cinnamon's potential for preventing the metabolic syndrome.

Keywords: Cinnamon, Spice, Diabetes, Metabolic syndrome, Inflammation, Insulin

Go to:

Introduction

The genus Cinnamon is an aromatic tree belonging to the family Lauraceae, and is one of the most widely studied flowering families, comprising about 250 species. Members of this family are evergreen trees, up to 10-17 m high, that grow in south-eastern Asia, Australia, and South America (Cheng, 1983). The flowers are bisexual, colored yellow with 9 stamens, and the fruits occur mostly as 10-15- mm long black ellipsoids (Cheng, 1983). Traditional uses of Cinnamon throughout Asia, Africa, and Europe have been recorded, where it has been used as a medicine for diarrhea, nausea and chill, or as a spice for seasoning meats. Cinnamon bark (肉桂 ròu guì) is an important source for these purposes, since it contains a great amount of the function-bearing essential oil. The bark-derived cinnamon (termed cinnamon hereafter) contains 45% ~65% cinnamaldehyde, 12% ~18% eugenol (Cheng, 1983) and small amounts of cinnzeylanine, cinnzeylanol, arabinoxylan, 2’-hydroxycinnamalde-hyde, and 2’-benzoloxycinnamaldehyde (Lee, 1999). As a major ingredient, cinnamaldehyde has been well investigated; and its diverse biological activities against central nervous system depression (Harada, 1976) and high blood pressure (Harada, 1975), as well as its analgesic effect (Harada, 1972), have been reported. A water extract of cinnamon was reported to have anti-allergic, anti-inflammatory (Nagai, 1982a; 1982b; 1982c), antipyretic, analgesic (Ozaki,1972) and antithrombotic effects (Terasawa, 1983). Recently, the interest of investigators seems to have shifted to become narrowly centered on the verification of cinnamon's potential for preventing the metabolic syndrome (Kannappan, 2006; Blevins, 2007) and diabetes (Anderson, 2004; Chase, 2007; Pham, 2007; Shen, 2010).

This review summarizes the up-to-date and comprehensive information on cinnamon regarding its traditional use, for which modern scientists have solved its pharmacological functions together with its toxicological aspects. Then we discuss a possible trend and scope for future research on cinnamon.

Go to:

Cinnamon as a traditional medicine

Trees belonging to the genus Cinnamomum are one of the major materials used in traditional Chinese medicine. Preparations containing the bark of Cinnamon have been prescribed for more than 2000 years in China, where the first record of its use was described in the Divine Husbandman's Herbal Foundation Canon (see the review introduced by Cheng, 1983). Owing to its roles in dispelling colds (祛寒 qū hán), threading an occluded vasa vasorum, and controlling yin/yang (陰 陽 yīn yang) as mentioned in the old Chinese literature, cinnamon has been widely used in China and Japan for the treatment of fever and inflammation as well as for improvement of an appetite depressed by influenza or the common cold (Cheng, 1983). In addition, cinnamon has been used as an aromatic for the preparation of fruit juices, wine, and cakes as well as for cooking meat. Cinnamon extracts have been used for the improvement of or protection against the common cold, diarrhea, and pain (Cheng, 1983). It has also been reported that the cinnamon ameliorates nephritis, purulent dermatitis, and hypertension, as well as potentiates wound healing, even that due to snake or viper bites (Nagai, 1982a; 1982b; Cheng, 1983). However, these effects are not fully supported by experimental or clinical data so far.

Go to:

Functional components in Cinnamomum plants

Cinnamaldehyde is a major constituent (45~65% of the essential oil in cinnamon bark) of the plants belonging to genus Cinnamomum (Cheng, 1983). Eugenol is contained as a second major constituent; and cinnzeylanine, cinnzeylanol (Isogai, 1977), arabinoxylan (Gowda, 1987), 2’-hydroxycinnamaldehyde, and 2’-benzoloxycinnamaldehyde (Lee, 1999) are also detected. Chemical structures of these compounds are shown in Fig. 1. A hot-water extract of cinnamon sticks (dried barks of cinnamon trees) yields 8.5 mg/ml cinnamaldehyde and 3.6 mg/ml cinnamyl alcohol (Shen, 2010).

Open in a separate window

Figure 1

Compounds found in the Cinnamon barks

Go to:

Pharmacological effects of cinnamon

In vitro and in vivo studies on cinnamon extracts or its components (mainly cinnamaldehyde) revealed that these substances exhibit a wide variety of pharmacological effects, such as antifungal, anti-cardiovascular, anticancer, antiinflammatory, antiulcer, antidiabetes, antiviral, antihypertensive, antioxidant, and cholesterol- and lipid-lowering ones. Some of the relevant literature on these therapeutic effects is summarized in Table 1, and some of the observations made are discussed in the following sections.

Table 1

Pharmacological activity of cinnamon and its compounds

Antifungal effect

The antifungal activity of cinnamaldehyde, which is used as a vapor to treat respiratory tract mycoses, has been reported. Cinnamon tree power (we usually call it “cinnamon”) acts against infectious fungi including Aspergillus niger, A. fumigatus, A. nidulans, A. flavus, Candida albicans, C. tropicalis, C. pseudotropicalisand Histoplasma capsulatum (Singh, 1995; Lima, 1993; Quale, 1996). In these cited studies, the following data were reported: the minimum inhibitory concentration (MIC), minimum lethal concentration (MLC) and exposure duration for its fungicidal action at MIC and higher doses, as well as incubation temperatures for expression‎ of its fungitoxicity. The inhalation of cinnamaldehyde appears to be an ideal chemotherapy against respiratory tract mycoses.

Effects on cardiovascular system and gastrointestinal tract

Cinnamophilin in cinnamon was found to be a thromboxane A2 (TXA2) receptor-blocking agent; and therefore its antagonistic effect was shown in TXA2-induced human platelet aggregation, rat aortic ring contraction, and contraction of guinea pig tracheal rings (Yu, 1994a). Intravenous administration of arachidonic acid (50 μg/kg body weight) to a guinea pig induces bronchoconstriction, whereas when cinnamophilin is pre-administered (0.1 mg/kg body weight, i.v. at 1 min before arachidonic acid), the bronchoconstriction is abolished (Yu, 1994a). Cinnamophilin (1-15 μM) also possesses a voltage-dependent Ca2+ channel-blocking action, which was judged from its antagonism toward high K+(60 mM)- and Bay K 8644 (0.1 μM)-induced contraction of rat thoracic aorta (Yu, 1994b). Su et al. demonstrated that the inhibition of sodium inward current, calcium inward current, and transient outward currents of both may contribute to the anti-arrhythmic activity of cinnamophilin against ischemia-reperfusion arrhythmia (Su, 1999).

Anticancer and immunomodulatory activities

An early study on water-soluble extracts of cinnamon showed that it increases the glutathione S-transferase (GST) activity in mice administered urethane, a carcinogenic substance, and prevents carcinogenesis (Abraham, 1998). Furthermore, an aqueous extract of cinnamon reduces cellular proliferation and blocks the cell cycle of Jurkat, Wurzburg, and U937 cells at the G2/M phase (Schoene, 2005). Cinnamaldehyde or its source C. cassia powder is reportedly a potent inducer of apoptosis in human promyelocytic leukemia cells, in which the aldehyde stimulates an apoptotic cascade leading to the activation of caspase-3 (Ka, 2003, Nishida, 2003). 2’-Hydroxycinnamaldehyde and 2’-benzoloxycinnamaldehyde isolated from the bark of C. cassia show cytotoxicity against several human solid tumor cells such as HCT-15 and SK-MEL-2 cells (Lee, 1999). Koh et al. (1998) reported that both of these compounds inhibit lymphocyte proliferation and modulate T-cell differentiation in vitro.

Antiulcerative activity

The antiulcerative effect of a cinnamon extract has not yet been clarified, but the effect of a water extract of cinnamon on serotonin-induced gastric lesions in mice was studied. A palliative effect is observed after oral administration of the extract at a dosage of 5–10 mg/kg body weight (Keller, 1992).

Antiinflammatory activity

Nagai et al. (1982a, 1982b) proved that complementdependent reactions including reversed passive cutaneous anaphylaxis, Forssman cutaneous vasculitis, nephrotoxic serum nephritis classified as type II, and the Arthus reaction classified as type III are clearly inhibited by an aqueous extract of C. cassia. However, this extract does not affect the nephritis caused by the F(ab’)2 portion of the nephrotoxic IgG antibody. The aqueous extract of C. cassia at a high concentration (200 mg/kg body weight) inhibits the immunological hemolysis and the chemotactic migration of neutrophils caused by activated serum complement as well as the generation of chemotactic factors. They also showed that the type IV reaction found in contact dermatitis is not affected by the aqueous extract of C. cassia but that the production of hemolytic plaque-forming cells is slightly inhibited by it. Their findings suggest that an aqueous extract of C. cassia has an anti-complement activity and inhibits complement-dependent allergic reactions.

Antioxidant activity

Mancini-Filho et al. (1998) demonstrated the antioxidant activity of cinnamon extracts by using an oxidative β-carotene/linoleic acid system, and they suggested that the cinnamon extracts can be used not only for improvement of food palatability but also for prevention of food oxidation.

Cinnamon bark extracts prepared with water and alcohol as well as its essential oil were tested in two different in vitro systems, i.e., peroxynitrite-induced nitration and lipid peroxidation. The essential oil and its component eugenol both show antioxidant activity in these systems (Shobana, 2000; Dragland, 2003; Khan, 2003; Chericoni, 2005; Kim, 2006a).

Cinnamon barks from C. zeylanicum, C. cassia or other cinnamon species are reported to exhibit antioxidant and free radical-scavenging activities, some of which were measured by using 1,1-diphenyl-2-picrylhydrazine (DPPH; Mancini-Filho, 1998; Shobana, 2000; Okawa, 2001; Dragland, 2003).

Cholesterol- and lipid-lowering effects

Administration of cinnamon to mice increases their HDL-cholesterol level and decreases their plasma triglyceride one (Kim, 2006a). Khan et al. (2003) reported that cinnamon improves the blood glucose, triglyceride, total cholesterol, HDL cholesterol and LDL cholesterol levels in patients with type 2 diabetes.

Antidiabetes effect

Recently, the anti-diabetic effect of cinnamon has been studied intensively by many investigators (Anderson, 2004; Chase, 2007; Pham, 2007; Shen, 2010). They commonly found that cinnamon improves insulin resistance and glucose metabolism in vitro and in vivo (Subash, 2007; Kannappan, 2006; Kim, 2006a; Berrio, 1992; Broadhurst, 2000; Cao, 2007; Imparl-Radosevich, 1998; Jarvill-Taylor, 2001; Khan, 1990; Kim, 2006b; Kreydiyyeh, 2000; Lee, 2011; Roffey, 2006; Taher, 2004; Talpur, 2005; Onderoglu, 1999; Qin; 2003; Qin, 2004; Verspohl, 2005). Among the components of cinnamon, cinnamaldehyde significantly and dose-dependently decreases the plasma glucose concentration of streptozotocin-induced diabetic rats (Subash, 2007). Regarding the mechanism underlying these effects, Shen et al. (2010) reported that cinnamon extracts promote the transportation of glucose by glucose transporter 4 in brown adipose tissue and muscles. Clinical research studies support the positive effects of cinnamon on both types 1 and 2 diabetes mellitus (Mang, 2006; Suppapitiporn, 2006; Vanschoonbeek, 2006; Altschuler, 2007; Blevins, 2007; Wang, 2007).

Go to:

Conclusions

As has been reported, cinnamon, as forms of bark, bark powder, extracts or its isolated components, has multifunctional activities promoting the health of human beings. Different from therapeutic drugs, cinnamon can be used daily in our diet without ill effect. Therefore, it may be preventive especially against the lifestyle-related illness or metabolic syndrome.

Although we did not mention in this review on cinnamon that it is also a representative agonist of the transient receptor potential A1 (TRPA1) cation channel (Iwasaki, 2008), many of the pharmacological activities of cinnamon might be exhibited via this receptor; e.g. the effects on cardiovascular and gastrointestinal systems might be regulated more or less by nervous systems via TRPA1. The anticancer and antiinflammatory activities could also be explained partly by sympathetic nerves stimulated via TRPA1.

Taking the self-protective antifungal and antioxidant activities of cinnamon into account, cinnamaldehyde, cinnamophilin, and other components possess both direct and indirect activities; i.e., the antifungal and antioxidant activities occur by direct action on fungus or oxidant, whereas the antidiabetic, anticancer, and antiinflammatory ones occur indirectly via some yet undefined receptor-mediated mechanisms.

The remarkable health benefits of cinnamon prompt us to explore derivatives of cinnamon that might be much more useful structures for overcoming the metabolic syndrome.

Go to:

References

1. Abraham S.K., Singh S.P., Kesavan P.C. In vivo antigenotoxic effects of dietary agents and beverages co-administered with urethane: assessment of the role of glutathione S-transferase activity. Mutat Res. 1998;413:103–110. [PubMed] [Google Scholar]

2. Altschuler J.A., Casella S.J., Mac Kenzie T.A., Curtis K.M. The effect of cinnamon on A1C among adolescents with type 1 diabetes. Diabetes Care. 2007;30:813–816. [PubMed] [Google Scholar]

3. Anderson R.A., Broadhurst C.L., Polansky M.M., Schmidt W.F., Khan A., Flanagan V.P., Schoene N.W., Graves D.J. Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J Agric Food Chem. 2004;52:65–70. [PubMed] [Google Scholar]

4. Berrio L.F., Polansky M.M., Anderson R.A. Insulin activity: stimulatory effects of cinnamon and brewer's yeast as influenced by albumin. Horm Res. 1992;37:225–229. [PubMed] [Google Scholar]

5. Blevins S.M., Leyva M.J., Brown J., Wright J., Scofiekd R.H., Aston C.E. Effect of cinnamon on glucose and lipid levels in non insulin-dependent type 2 diabetes. Diabetes Care. 2007;30:2236–2237.[PubMed] [Google Scholar]

6. Broadhurst C.L., Polansky M.M., Anderson R.A. Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. J Agric Food Chem. 2000;48:849–852. [PubMed] [Google Scholar]

7. Cao H., Polansky M.M., Anderson R.A. Cinnamon extract and polyphenols affect the expression‎ of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch Biochem Biophys. 2007;459:214–222. [PubMed] [Google Scholar]

8. Chase C.K., Mc Queen C.E. Cinnamon in diabetes mellitus. Am J Health Syst Pharm. 2007;64:1033–1035. [PubMed] [Google Scholar]

9. Chen Y. Pharmacological studies of Cinnamomum cassia bark. Part I. Effects on the blood and cardiovascular system. Zhong Yao Tong Bao. 1981;6:32–34. [PubMed] [Google Scholar]

10. Cheng B.C. A review of cinnamon. Zhong Cao Yao. 1983;14:134. [Google Scholar]

11. Chericoni S., Prieto J.M., Iacopini P., Cioni P., Morelli I. In vitro activity of the essential oil of Cinnamomum zeylanicum and eugenol in peroxynitrite-induced oxidative processes. J Agric Food Chem. 2005;53:4762–4765. [PubMed] [Google Scholar]

12. Dragland S., Senoo H., Wake K., Holte K., Blomhoff R. Several culinary and medicinal herbs are important sources of dietary antioxidants. J Nutr. 2003;133:1286–1290. [PubMed] [Google Scholar]

13. Gowda D.C., Sarathy C. Structure of an L-arabino-D- xylan from the bark of Cinnamomum zeylanicum. Carbohydrate Res. 1987;166:263–269. [Google Scholar]

14. Harada M., Fujii Y., Kamiya J. Pharmacological studies on Chinese cinnamon. III. Electroencephalographic studies of cinnamaldehyde in the rabbit. Chem Phar Bull. 1976;24:1784–1788.[PubMed] [Google Scholar]

15. Harada M., Ozaki Y. Pharmacological studies on Chinese cinnamon. I. Central effects of cinnamaldehyde. Yakugaku Zasshi. 1972;92:135–140. [PubMed] [Google Scholar]

16. Harada M., Yano S. Pharmacological studies on Chinese cinammon. II. Effects of cinnamaldehyde on the cardiovascular and digestive systems. Chem Pharm Bull. 1975;23:941–947. [PubMed] [Google Scholar]

17. Hayashi K., Imanishi N., Kashiwayama Y., Kawano A., Terasawa K., Shimada Y., Ochiai H. Inhibitory effect of cinnamaldehyde, derived from Cinnamomi cortex, on the growth of influenza A/PR/8 virus in vitro and in vivo. Antiviral Res. 2007;74:1–8. [PubMed] [Google Scholar]

18. Imparl-Radosevich J., Deas S., Polansky M.M., Baedke D.A., Ingebritsen T.S., Anderson R.A., Graves D.J. Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signaling. Horm Res. 1998;50:177–182. [PubMed] [Google Scholar]

19. Isogai A., Murakoshi S., Suzuki A., Tamura S. Chemistry and biological activities of cinnzeylanine and cinnzeylanol, new insecticidal substances from Cinnamonum zeylanicum nees. Agric Biol Chem. 1977;41:1779–1784. [Google Scholar]

20. Iwasaki Y., Tanabe M., Kobata K., Watanabe T. TRPA1 agonists--allyl isothiocyanate and cinnamaldehyde--induce adrenaline secretion. Biosci Biotechnol Biochem. 2008;72:2608–2614. [PubMed] [Google Scholar]

21. Jarvill-Taylor K.J., Anderson R.A., Graves D.J. A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes. J Am Coll Nutr. 2001;20:327–336. [PubMed] [Google Scholar]

22. Ka H., Park H.J., Jung H.J., Choi J.W., Cho K.S., Ha J., Lee K.T. Cinnamaldehyde induces apoptosis by ROS-mediated mitochondrial permeability transition in human promyelocytic leukemia HL-60 cells. Cancer Lett. 2003;196:143–152. [PubMed] [Google Scholar]

23. Kannappan S., Jayaraman T., Rajasekar P., Ravichandtan M.K., Anuradha C.V. Cinnamon bark extract improves glucose metabolism and lipid profile in the fructose-fed rat. Singapore Med J. 2006;47:858–863.[PubMed] [Google Scholar]

24. Keller KIn.  Desmet PAGM ed Adverse effect of herbal drugs. I. Berlin: Springer-Verlag; 1992. Cinnamomum species; pp. 105–114. [Google Scholar]

25. Khan A., Safdar M., Ali Khan M.M., Khattak K.N., Anderson R.A. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003;26:3215–3218. [PubMed] [Google Scholar]

26. Khan A., Bryden N.A., Polansky M.M., Anderson R.A. Insulin potentiating factor and chromium content of selected foods and spices. Biol Trace Elem Res. 1990;24:183–188. [PubMed] [Google Scholar]

27. Kim S.H., Hyun S.H., Choung S.Y. Anti -diabetic effect of cinnamon extract on blood glucose in db/db mice. J Ethnopharmacol. 2006a;104:119–123. [PubMed] [Google Scholar]

28. Kim W., Khil L.Y., Clark R., Bok S.H., Kim E.E., Lee S., Jun H.S., Yoon J.W. Naphthalenemethyl ester derivative of dihydroxyhydrocinnamic acid, a component of cinnamon, increases glucose disposal by enhancing translocation of glucose transporter 4. Diabetologia. 2006b;49:2437–2448. [PubMed] [Google Scholar]

29. Koh W.S., Yoon S.Y., Kown B.M. Cinnamaldehyde inhibits lymphocyte proliferation and modulates T-cell differentiation. Int J Immunopharmacol. 1998;20:643–660. [PubMed] [Google Scholar]

30. Kreydiyyeh S.I., Usta J., Copti R. Effect of cinnamon, clove and some of their constituents on the Na(+)-K(+)-ATPase activity and alanine absorption in the rat jejunum. Food Chem Toxicol. 2000;38:755–762. [PubMed] [Google Scholar]

31. Lee C.W., Hing D.H., Han S.B. Inhibition of human tumor growth by 2’- hydroxyl- and 2’- benzoloxycinnamaldehyde. Planta Med. 1999;65:263–266. [PubMed] [Google Scholar]

32. Lee T., Dugoua J.J. Nutritional supplements and their effect on glucose control. Curr Diab Rep. 2011;11:142–148. [PubMed] [Google Scholar]

33. Lima E.O., Gompertz O.F., Giesbrecht A.M., Paulo M.Q. In vitro antifungal activity of essential oils obtained from officinal plants against dermatophytes. Mycoses. 1993;36:333–336. [PubMed] [Google Scholar]

34. Mancini-Filho J., Van-Koiij A., Mancini D.A., Cozzolino F.F., Torres R.P. Antioxidant activity of cinnamon (Cinnamomum Zeylanicum, Breyne) extracts. Boll Chim Farm. 1998;137:443–447. [PubMed] [Google Scholar]

35. Mang B., Wolters M., Schmitt B., Kelb K., Lichtinghagen R., Stichtenoth D.O., Hahn A. Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest. 2006;36:340–344. [PubMed] [Google Scholar]

36. Nagai H., Shimazawa T., Matsuura N., Koda A. Immuno pharmacological studies of the aqueous extract of Cinnamomum cassia (CCAq). I. Anti-allergic action. Jpn J Pharmacol. 1982a;32:813–822.[PubMed] [Google Scholar]

37. Nagai H., Takizawa T., Nishiyori T., Koda A. Experimental glomerulonephritis in mice as a model for immunopharmacological studies. Jpn J Pharmacol. 1982b;32:1117–1124. [PubMed] [Google Scholar]

38. Nagai H., Shimazawa T., Takizawa T., Koda A., Yagi A., Nishioka I. Immunopharmacological studies of the aqueous extract of Cinnamomum cassia (CCAq). II. Effect of CCAq on experimental glomerulonephritis. Jpn J Pharmacol. 1982c;32:823–831. [PubMed] [Google Scholar]

39. Nishida S., Kikuichi S., Yoshioka S., Tsubaki M., Fujii Y., Matsuda H., Kubo M., Irimajiri K. Induction of apoptosis in HL-60 cells treated with medicinal herbs. Am J Chin Med. 2003;31:551–562. [PubMed] [Google Scholar]

40. kawa M., Kinjo J., Nohara T., Ono M. DPPH (1,1-diphenyl-2- picrylhydrazyl) radical scavenging activity of flavonoids obtained from some medicinal plants. Biol Pharm Bull. 2001;24:1202–1205.[PubMed] [Google Scholar]

41. Onderoglu S., Sozer S., Erbil K.M., Ortac R., Lermioglu F. The eval‎uation of long-term effects of cinnamon bark and olive leaf on toxicity induced by streptozotocin administration to rats. J Pharm Pharmacol. 1999;51:1305–1312. [PubMed] [Google Scholar]

42. Pham A.Q., Kourlas H., Pham D.Q. Cinnamon supplement ationin patients with type 2 diabetes mellitus. Pharmacotherapy. 2007;27:595–599. [PubMed] [Google Scholar]

43. Premanathan M., Rajendran S., Ramanathan T., Kathiresan K., Nakashima H., Yamamoto N. A survey of some Indian medicinal plants for anti-human immunodeficiency virus (HIV) activity. Indian J Med Res. 2000;112:73–77. [PubMed] [Google Scholar]

44. Preuss H.G., Echard B., Polansky M.M., Anderson R. Whole cinnamon and aqueous extracts ameliorate sucrose-induced blood pressure elevations in spontaneously hypertensive rats. J Am Coll Nutr. 2006;25:144–150. [PubMed] [Google Scholar]

45. Qin B., Nagasaki M., Ren M., Bajotto G., Oshida Y., Sato Y. Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. Diabetes Res Clin Pract. 2003;62:139–148. [PubMed] [Google Scholar]

46. Qin B., Nagasaki M., Ren M., Bajotto G., Oshida Y., Sato Y. Cinnamon extract prevents the insulin resistance induced by a high-fructose diet. Horm Metab Res. 2004;36:119–125. [PubMed] [Google Scholar]

47. Quale J.M., Landman D., Zaman M.M., Burney S., Sathe S.S. In vitro activity of Cinnamomum zeylanicum against azole resistant and sensitive Candida species and a pilot study of cinnamon for oral candidiasis. Am J Chin Med. 1996;24:103–109. [PubMed] [Google Scholar]

48. Roffey B., Atwal A., Kubow S. Cinnamon water extracts increase glucose uptake but inhibit adiponectin secretion in 3T3-L1 adipose cells. Mol Nutr Food Res. 2006;50:739–745. [PubMed] [Google Scholar]

49. Schoene N.W., Kelly M.A., Polansky M.M., Anderson R.A. Water-soluble polymeric polyphenols from cinnamon inhibit proliferation and alter cell cycle distribution patterns of hematologic tumor cell lines. Cancer Lett. 2005;230:134–140. [PubMed] [Google Scholar]

50. Shen Y., Fukushima M., Ito Y., Muraki E., Hosono T., Seki T., Ariga T. Verification of antidiabetic effects of cinnamon (Cinnamomum zeylanicum) using insulin-uncontrolled type 1 diabetic rats and cultured adipocytes. Biosci Biotec Biochem. 2010;74:2418–2425. [PubMed] [Google Scholar]

51. Shobana S., Naidu K.A. Antioxidant activity of selected Indian spices. Prostaglandins Leukot Essent Fatty Acids. 2000;62:107–110. [PubMed] [Google Scholar]

52. Singh H.B., Srivastava M., Singh A.B., Srivastava A.K. Cinnamon bark oil, a potent fungitoxicant against fungi causing respiratory tract mycoses. Allergy. 1995;50:995–999. [PubMed] [Google Scholar]

53. Su M.J., Chen W.P., Lo T.Y., Wu T.S. Ionic mechanisms for the antiarrhythmic action of cinnamophilin in rat heart. J Biomed Sci. 1999;6:376–386. [PubMed] [Google Scholar]

54. Subash Babu P., Prabuseenivasan S., Ignacimuthu S. Cinnamaldehyde-a potential antidiabetic agent. Phytomedicine. 2007;14:15–22. [PubMed] [Google Scholar]

55. Suppapitiporn S., Kanpaksi N., Suppapitiporn S. The effect of cinnamon cassia powder in type 2 diabetes mellitus. J Med Assoc Thai. 2006;89:S200–205. [PubMed] [Google Scholar]

56. Tabak M., Armon R., Neeman I. Cinnamon extracts’ inhibitory effect on Helicobacter pylori. J Ethnopharmacol. 1999;67:269–277. [PubMed] [Google Scholar]

57. Taher M., Abdul Majid F.A., Sarmidi M.R. Cinnamtannin B1 activity on adipocyte formation. Med J Malaysia. 2004;59(Suppl B):97–98. [PubMed] [Google Scholar]

58. Talpur N., Echard B., Ingram C., Bagchi D., Preuss H. Effects of a novel formulation of essential oils on glucose-insulin metabolism in diabetic and hypertensive rats: a pilot study. Diabetes Obes Metab. 2005;7:193–199. [PubMed] [Google Scholar]

59. Terasawa K., Kimura M., Sakuragawa N., Uchiyama Y., Toriizuka K., Ueno M., Horikoshi I. Effects of anti- “Oketsu” drugs on blood coagulation and fibrinolysis. Yakugaku Zasshi. 1983;103:313–318.[PubMed] [Google Scholar]

60. Vanschoonbeek K., Thomassen B.J., Senden J.M., Wodzig W.K., van Loon L.J. Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients. J Nutr. 2006;136:977–980. [PubMed] [Google Scholar]

61. Verspohl E.J., Bauer K., Neddermann E. Antidiabetic effect of Cinnamomum cassia and Cinnamomum zeylanicum in vivo and in vitro. Phytother Res. 2005;19:203–206. [PubMed] [Google Scholar]

62. Wang J.G., Anderson R.A., Graham GMIII, Chu M.C., Sauer M.V., Guarnaccia M.M., Lobo R.A. The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study. Fertil Steril. 2007;88:240–243. [PubMed] [Google Scholar]

63. Yu S.M., Wu T.S., Teng C.M. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A 2 receptor. Br J Pharmacol. 1994a;111:906–912.[PMC free article] [PubMed] [Google Scholar]

64. Yu S.M., Ko F.N., Wu T.S., Lee J.Y., Teng C.M. Cinnamophilin a novel thromboxane A2 receptor antagonist, isolated from Cinnamomum philippinense. Eur J Pharmacol. 1994b;256:85–91. [PubMed] [Google Scholar]

65. Zhou L., Chen Z.X., Chen J.Y. Effect of wu lin powder and its ingredients on atrial natriuretic factor level in mice. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1995;15:36–37. [PubMed] [Google Scholar]